News about Global Pharma

Nxera Pharma Assigns Japan Rights to Cenerimod for Autoimmune Diseases to Viatris

Nxera will receive an upfront payment of USD 10 million from Viatris and is eligible to receive a milestone payment upon regulatory approval of cenerimod in Japan plus royalties on net sales should it be commercialized in the assigned territories.

Global Pharma | 28/02/2025 | By Aishwarya |  573

Venus Remedies Bags Exclusive Licensing Rights for MET-X from Infex Therapeutics

This strategic collaboration grants Venus Remedies the rights to spearhead clinical development, regulatory approvals, and commercialization of MET-X in India, focusing on its integration with meropenem to tackle infections resistant to conventional treatments.

Global Pharma | 28/02/2025 | By Aishwarya |  591

ProductLife Group Acquires Herax Life Science to Boost R&D Business

This acquisition unites HERAX Life Science and PLG under a shared commitment to accelerate drug development, streamline clinical trials, and ensure the highest standards of safety and compliance.

Global Pharma | 27/02/2025 | By Aishwarya |  261

Glenmark Pharmaceuticals Launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial in US

Glenmark Pharmaceuticals Inc., USA, has launched Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial, securing 180 days of CGT exclusivity.

Global Pharma | 27/02/2025 | By Manvi |  392

Lupin Secures Place in S&P Global Sustainability Yearbook 2025

Lupin Ltd. has been included in the S&P Global Sustainability Yearbook 2025 for the second consecutive year, recognising its strong commitment to sustainability and improved Corporate Sustainability Assessment (CSA) score.

Global Pharma | 27/02/2025 | By Manvi |  528

Abzena Welcomes Taylor Boyd as New CBO

Boyd has a strong track record of success within the life sciences and CDMO industry, primarily in strategic transactions and capital-raising activities.

Global Pharma | 27/02/2025 | By Aishwarya |  778

MediBeacon Transdermal GFR System Receives Device Approval in China

MediBeacon Inc. announced the National Medical Products Administration (NMPA) in China has approved the MediBeacon® TGFR Monitor and TGFR Sensor for the assessment of kidney function in patients with normal or impaired renal function.

Global Pharma | 26/02/2025 | By Manvi |  1145

Nimbus Therapeutics Hits Preclinical Research Milestone with Lilly

Throughout their collaboration, Nimbus has leveraged its computational approaches and structure-based drug design capabilities to help overcome these historical obstacles.

Global Pharma | 26/02/2025 | By Aishwarya |  452

Averto Medical's ColoSeal ICD System Earns FDA Breakthrough Device Designation

Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, announce that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its ColoSeal™ Intraluminal Colonic Diversion (ICD) System.

Global Pharma | 26/02/2025 | By Manvi |  706

PharmSight to Expand Globally with New Strategic Hub Launch in Boston

PharmSight plans to broaden its global footprint by opening new offices in Europe and the Middle East and launching an innovation center dedicated to AI-driven solutions.

Global Pharma | 26/02/2025 | By Aishwarya |  609